Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include Nektar Therapeutics.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 1999 | Founding Date 1990 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Needham, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US |
Employees | Employees 50 | Employees 61821% increase |
Valuation ($) | Valuation ($) 176.8 m | Valuation ($) 233.8 m |
Financial | ||
Net income | Net income ($38.2m) (FY, 2025) | Net income ($164.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 45m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View company